Annual EBITDA
-$24.79 M
-$45.48 M-219.79%
31 December 2023
Summary:
Evolent Health annual earnings before interest, taxes, depreciation & amortization is currently -$24.79 million, with the most recent change of -$45.48 million (-219.79%) on 31 December 2023. During the last 3 years, it has fallen by -$80.45 million (-144.53%). EVH annual EBITDA is now -107.07% below its all-time high of $350.45 million, reached on 31 December 2015.EVH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$11.96 M
-$25.27 M-67.88%
30 September 2024
Summary:
Evolent Health quarterly earnings before interest, taxes, depreciation & amortization is currently $11.96 million, with the most recent change of -$25.27 million (-67.88%) on 30 September 2024. Over the past year, it has increased by +$18.18 million (+291.99%). EVH quarterly EBITDA is now -96.81% below its all-time high of $375.20 million, reached on 31 December 2015.EVH Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$61.74 M
-$4.19 M-6.35%
30 September 2024
Summary:
Evolent Health TTM earnings before interest, taxes, depreciation & amortization is currently $61.74 million, with the most recent change of -$4.19 million (-6.35%) on 30 September 2024. Over the past year, it has increased by +$86.52 million (+349.09%). EVH TTM EBITDA is now -82.38% below its all-time high of $350.45 million, reached on 31 December 2015.EVH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVH EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +292.0% | +349.1% |
| 3 y3 years | -144.5% | -50.4% | +10.6% |
| 5 y5 years | +90.3% | +105.9% | +124.3% |
EVH EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -144.5% | at low | -67.9% | +126.0% | -6.3% | +253.7% |
| 5 y | 5 years | -144.5% | +90.3% | -67.9% | +105.9% | -6.3% | +113.5% |
| alltime | all time | -107.1% | +90.3% | -96.8% | +105.9% | -82.4% | +113.5% |
Evolent Health EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $11.96 M(-67.9%) | $61.74 M(-6.4%) |
| June 2024 | - | $37.22 M(+98.2%) | $65.92 M(+64.8%) |
| Mar 2024 | - | $18.79 M(-401.7%) | $40.00 M(-261.4%) |
| Dec 2023 | -$24.79 M(-219.8%) | -$6.23 M(-138.6%) | -$24.79 M(+862.5%) |
| Sept 2023 | - | $16.14 M(+42.9%) | -$2.58 M(-93.6%) |
| June 2023 | - | $11.30 M(-124.6%) | -$40.16 M(+4.3%) |
| Mar 2023 | - | -$46.00 M(-387.8%) | -$38.51 M(-286.1%) |
| Dec 2022 | $20.69 M(-62.8%) | $15.98 M(-174.5%) | $20.69 M(-28.2%) |
| Sept 2022 | - | -$21.44 M(-265.6%) | $28.83 M(-50.9%) |
| June 2022 | - | $12.95 M(-1.9%) | $58.69 M(+1.3%) |
| Mar 2022 | - | $13.20 M(-45.3%) | $57.91 M(+3.8%) |
| Dec 2021 | $55.66 M(-123.1%) | $24.12 M(+186.5%) | $55.82 M(+24.0%) |
| Sept 2021 | - | $8.42 M(-30.8%) | $45.03 M(+103.0%) |
| June 2021 | - | $12.17 M(+9.6%) | $22.19 M(-112.8%) |
| Mar 2021 | - | $11.11 M(-16.7%) | -$173.84 M(-27.8%) |
| Dec 2020 | -$240.74 M(-5.4%) | $13.33 M(-192.4%) | -$240.74 M(-47.5%) |
| Sept 2020 | - | -$14.42 M(-92.2%) | -$458.13 M(+1.5%) |
| June 2020 | - | -$183.85 M(+229.5%) | -$451.26 M(+61.7%) |
| Mar 2020 | - | -$55.80 M(-72.7%) | -$279.00 M(+9.6%) |
| Dec 2019 | -$254.52 M | -$204.06 M(+2603.2%) | -$254.52 M(+404.7%) |
| Sept 2019 | - | -$7.55 M(-34.9%) | -$50.43 M(+14.4%) |
| June 2019 | - | -$11.59 M(-63.0%) | -$44.09 M(+38.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$31.32 M(<-9900.0%) | -$31.76 M(+664.8%) |
| Dec 2018 | -$4.15 M(-89.7%) | $27.00 K(-102.2%) | -$4.15 M(-60.9%) |
| Sept 2018 | - | -$1.22 M(-262.2%) | -$10.61 M(-32.2%) |
| June 2018 | - | $749.00 K(-120.2%) | -$15.64 M(-45.9%) |
| Mar 2018 | - | -$3.71 M(-42.3%) | -$28.94 M(-28.4%) |
| Dec 2017 | -$40.40 M(-81.6%) | -$6.43 M(+3.0%) | -$40.40 M(-34.4%) |
| Sept 2017 | - | -$6.25 M(-50.2%) | -$61.56 M(-8.9%) |
| June 2017 | - | -$12.55 M(-17.3%) | -$67.60 M(+5.9%) |
| Mar 2017 | - | -$15.18 M(-45.0%) | -$63.81 M(-71.0%) |
| Dec 2016 | -$220.06 M(-162.8%) | -$27.59 M(+124.6%) | -$220.06 M(-220.4%) |
| Sept 2016 | - | -$12.29 M(+40.3%) | $182.73 M(+1.1%) |
| June 2016 | - | -$8.76 M(-94.9%) | $180.82 M(+1.0%) |
| Mar 2016 | - | -$171.43 M(-145.7%) | $179.03 M(-48.9%) |
| Dec 2015 | $350.45 M(>+9900.0%) | $375.20 M(-2744.1%) | $350.45 M(-1516.3%) |
| Sept 2015 | - | -$14.19 M(+34.4%) | -$24.75 M(+134.4%) |
| June 2015 | - | -$10.55 M(<-9900.0%) | -$10.55 M(<-9900.0%) |
| Mar 2015 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2014 | $0.00(-100.0%) | $0.00(0.0%) | -$10.99 M(0.0%) |
| Sept 2014 | - | $0.00(0.0%) | -$10.99 M(0.0%) |
| June 2014 | - | $0.00(-100.0%) | -$10.99 M(0.0%) |
| Mar 2014 | - | -$10.99 M | -$10.99 M |
| Dec 2013 | -$19.95 M | - | - |
FAQ
- What is Evolent Health annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Evolent Health?
- What is Evolent Health quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Evolent Health?
- What is Evolent Health quarterly EBITDA year-on-year change?
- What is Evolent Health TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Evolent Health?
- What is Evolent Health TTM EBITDA year-on-year change?
What is Evolent Health annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of EVH is -$24.79 M
What is the all time high annual EBITDA for Evolent Health?
Evolent Health all-time high annual earnings before interest, taxes, depreciation & amortization is $350.45 M
What is Evolent Health quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of EVH is $11.96 M
What is the all time high quarterly EBITDA for Evolent Health?
Evolent Health all-time high quarterly earnings before interest, taxes, depreciation & amortization is $375.20 M
What is Evolent Health quarterly EBITDA year-on-year change?
Over the past year, EVH quarterly earnings before interest, taxes, depreciation & amortization has changed by +$18.18 M (+291.99%)
What is Evolent Health TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of EVH is $61.74 M
What is the all time high TTM EBITDA for Evolent Health?
Evolent Health all-time high TTM earnings before interest, taxes, depreciation & amortization is $350.45 M
What is Evolent Health TTM EBITDA year-on-year change?
Over the past year, EVH TTM earnings before interest, taxes, depreciation & amortization has changed by +$86.52 M (+349.09%)